11/14/2024
4:49 PM | Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/14/2024
11:32 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:23 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:31 PM | Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:33 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:34 PM | Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:31 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/13/2024
6:32 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
6:33 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
5:15 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:17 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
12:45 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:32 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
4:17 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:34 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:11 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
08/09/2024
8:43 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
08/05/2024
11:54 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
07/15/2024
6:55 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:59 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
07/12/2024
3:55 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
5:20 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:26 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:04 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/28/2024
6:33 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
6:36 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/27/2024
4:01 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:01 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:02 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:04 PM | Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:05 PM | COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
8:04 AM | Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:04 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
4:14 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
I've got news for you… (Ad) Today, I’m doing something I thought I’d never do…
Especially since I’m not normally a “swing for the fences” type of trader.
But I’ve been quietly testing a new type of trade for a while now…
And the returns are too good not to share with you.
Take a look…
I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman |
05/09/2024
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:07 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:09 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/26/2024
6:55 AM | Lexeo Therapeutics (Filer)
Lexeo Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:56 AM | Lexeo Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:57 AM | Lexeo Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:57 AM | Lexeo Therapeutics (Filer)
| Form ARS | |
04/22/2024
7:22 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
7:23 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:24 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:11 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/16/2024
6:32 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
04/12/2024
4:04 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/09/2024
7:01 AM | Lexeo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/11/2024
8:29 AM | Lexeo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
3:43 PM | Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SC 13G | |
02/14/2024
3:34 PM | Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G | |
02/14/2024
12:43 PM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:04 AM | D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/06/2024
4:56 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:57 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
5:50 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:52 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:00 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
3:51 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
12/11/2023
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/11/2023
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:33 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G | |
Free LXEO Stock Alerts